An AI framework has been developed that analyzes multiple signals in cell-free DNA to detect cancer from blood samples. Using ...

Researchers have combined machine learning with portable biosensors to accurately detect a dangerous cyanobacterial toxin ...

When breast cancer is caught while it is still confined to the breast, the five-year relative survival rate is about 99%. Once it has spread to distant parts of the body, that figure falls to roughly ...

Portable screen-printed carbon electrode (SPCE) biosensors offer a rapid and low-cost way to detect microcystin-lysine-arginine (MC-LR), an extremely potent toxin produced by cyanobacteria during ...

An AI tool built to find faint cancer markers in routine tissue slides is headed for lab trials, as QIMR Berghofer tests a ...

Investigating breast cancer and atrial fibrillation overlap, this study highlights key risk factors, underscoring the need ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today announced a collaboration with Priority Health, a nationally recognized nonprofit health plan and ...

A machine learning model adjusts toxin readings for water-quality variability, enabling faster, lower-cost on-site testing without repeated recalibration CHUNGCHEONG PROVINCE, South Korea, July 10, ...

Inspirata today announced it has rebranded as Inspirata AI, marking a new chapter powered by enhanced, native AI-driven cancer casefinding, data abstraction, and reporting capabilities and a ...

India’s healthcare system faces a challenge of extraordinary scale: 1.4 billion people, a doctor-to-patient ratio of 1:834 ...

Discover how protein biosensors can revolutionize emergency medicine by providing rapid, real-time diagnostics for critical ...